Patent · US Revoked

Antisense antibacterial method and compound

US9487784B2 · kind B2 · utility

0Cited by
34References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 19, 2012
Grant dateNov 8, 2016
Priority date
Expiry dateNov 19, 2032

Classification

  • Technology area (CPC —)General

Abstract

A method and antisense compound for inhibiting the growth of pathogenic bacterial cells are disclosed. The compound contains no more than 12 nucleotide bases and has a targeting nucleic acid sequence of no fewer than 10 bases in length that is complementary to a target sequence containing or within 10 bases, in a downstream direction, of the translational start codon of a bacterial mRNA that encodes a bacterial protein essential for bacterial replication. The compound binds to a target mRNA with a Tm of between 50° to 60° C. The relatively short antisense compounds are substantially more active than conventional antisense compounds having a targeting base sequence of 15 or more bases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.